16:47 EST Pelthos Therapeutics (PTHS) files $200M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTHS:
- Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer
- Horizon Technology provides $50M loan facility to Pelthos Therapeutics
- Pelthos Therapeutics Secures $50 Million Venture Loan Financing
- Pelthos Therapeutics secures up to $50M senior secured term loan
- Pelthos Therapeutics Details Q1 2026 Growth Strategy
